UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Status:
Recruiting
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludarabine/total body
irradiation (TBI) preparative regimen with modifications based on factors including
diagnosis, disease status, and prior treatment. Single or double unit selected according to
current University of Minnesota umbilical cord blood graft selection algorithm.